Barriers to initiating insulin therapy in patients with type 2 Diabetes mellitus in public-sector primary health care centres  in Cape Town by Haque, Monirul et al.
October 2005, Vol. 95, No. 10  SAMJ
ORIGINAL ARTICLES
798
Based on available epidemiological data,1-4 it was estimated
that during the last decade approximately 1.5 million South
Africans had diabetes mellitus.1-4 This figure is likely to be
higher today as the prevalence of diabetes is growing
worldwide, with the greatest increase occurring in developing
countries.
The main challenge in diabetes management is to optimise
quality of life and to prevent well-known morbidity and
premature mortality.  This can only be achieved with quality
diabetes care, adequate resources and in people with diabetes
who are informed, motivated and empowered.  In South
Africa, the majority of people with diabetes receive less than
optimal care at the primary level. Many deficiencies have been
reported such as infrequent assessment of complications,
suboptimal glycaemic and blood pressure (BP) control, and
failure to advance therapy to achieve therapeutic goals.5-9 In
particular, although insulin is required to achieve acceptable
glycaemic control, often it is not prescribed.6,9 This suboptimal
treatment is especially relevant as attainment of good
glycaemic control reduces the risk of microvascular
complications.10,11
Common barriers to primary-level diabetes care in South
Africa have been attributed to financial and time constraints,
lack of patient compliance, and language and cultural
differences. It has also been noted that there is a deficiency in
staff knowledge with regard to diabetes.12 In a survey of
medical officers (MOs) regarding national guidelines for
hypertension and diabetes, insufficient resources and time,
overcrowded clinics, poor patient records, lack of MO
education on guidelines, decreasing staff numbers, few
opportunities for continuing medical education (CME) and
poor patient compliance were cited as barriers to guideline
implementation.13 Similar findings have also been reported
from the USA.14-18
As attainment of good glycaemic control is critical to
improving outcomes in people with diabetes, this qualitative
study was conducted to identify and explore barriers to the
initiation of insulin therapy in patients with poorly controlled
type 2 diabetes who are being prescribed maximum doses of
oral medication by MOs in community health centres (CHCs)
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Background. The majority of patients with type 2 diabetes
mellitus in Cape Town who attend primary care community
health centres (CHCs) have unsatisfactory glycaemic control.
Insulin is rarely prescribed despite its being indicated for type
2 diabetic patients with inadequate metabolic control on
maximum oral glucose-lowering agent (OGLA) therapy.
Objective. The study examined barriers to initiating insulin
therapy in poorly controlled type 2 diabetes patients on
maximum OGLAs in CHCs in the Cape Town metropole.
Methods. Five focus group discussions and 10 in-depth semi-
structured individual interviews were conducted with 46
medical officers working at the CHCs. The discussions and
interviews were transcribed and common themes were
identified and categorised.
Results. Doctor, patient, and system barriers to initiating insulin
therapy were identified. Doctors’ barriers include lack of
knowledge, lack of experience with and use of guidelines
related to insulin therapy, language barriers between doctor
and patients, and fear of hypoglycaemia. Patient barriers were
mistaken beliefs about insulin, non-compliance, lack of
understanding of diabetes, use of traditional herbs, fear of
injections, and poor socioeconomic conditions. System barriers
were inadequate time, lack of continuity of care and financial
constraints.
Conclusion. Suggestions for overcoming barriers include further
education of doctors on insulin initiation and the use of
standardised guidelines. In addition, a patient-centred
approach with better communication between doctors and
patients, which may be achieved by reorganising aspects of the
health system, may improve patient knowledge, address
mistaken beliefs, improve compliance and help overcome
barriers. Further research is needed to investigate these
recommendations and assess patients’ and nurses’ perceptions
on initiating insulin therapy.
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in the Cape Town metropole.  These 44 CHCs are run by the
Community Health Services Organisation (CHSO) of the
Department of Health of the Provincial Administration of the
Western Cape (PAWC) and provide comprehensive primary
services for a population of 3 million in the Cape Town
metropole.
Study methods
Five focus group discussions followed by 10 in-depth
individual semi-structured interviews were conducted with
MOs at CHCs throughout the Cape Town metropolitan region.
These were tape recorded and transcribed verbatim.  Written
informed consent from participants and approval from the
Ethics Committee of the University of Cape Town were
obtained.  The data were collected from December 2000 to
August 2001.
Sample
The CHSO has 140 MOs, with work experience ranging from 6
months to 20 years; they are categorised as community service
medical officers (first year post-intern medical doctor), junior
medical officers (1 - 3 years’ post-internship service), senior
medical officers (4 - 10 years’ experience), and principal
medical officers (more than 10 years’ experience).
Focus groups
Sampling was purposeful, with the intention of including MOs
of various ranks but with similar practice experience in each
group. Fifteen MOs were contacted and invited to participate
in each group. There were finally 5 - 11 participants per group
representing all ranks of MOs.
An interview guide was developed and included questions
on: (i) doctors’ feelings and experience with initiating insulin
therapy and patients’ reactions to such therapy; (ii) whether
patient knowledge, socio-economic status, and/or culture
affected doctors’ decisions to prescribe insulin; and (iii) doctor
perception with regard to attitudes of fellow doctors.  Each
group discussion was led by 1 of 4 qualitative researchers.  A
note-taker observed and recorded non-verbal reactions and
interaction of participants.
In-depth individual interviews
In-depth individual interviews were conducted with 10 doctors
who had not participated in the focus group discussions. Work
experience of the doctors ranged between 2 and 22 years. The
interviews included a series of open-ended questions derived
from focus group discussion analyses.  Questions focused on
doctor knowledge and experience related to insulin therapy,
use of guidelines for insulin therapy and perception of health
system factors influencing insulin therapy.  Interviews were
conducted by 1 of 2 qualitative researchers.
Analysis
Data were analysed immediately after each focus group
discussion according to grounded theory methodology.
Common themes were identified, coded, and categorised, first
within focus group discussions and then separately for
individual interviews.  The interrelationships of the different
categories were examined in order to generate a more
conceptual understanding of the barriers to insulin therapy.
Validity was enhanced by comparing the researchers’ findings
with those of 2 independent investigators who had analysed
both groups.  Results of the in-depth interviews were further
validated by feedback to the participants.
Results
The study identified numerous barriers, which fell into three
main categories or themes: (i) MO-related; (ii) patient-related;
and (iii) system-related.
MO-related
MO barriers were related to lack of knowledge, training and
skills. 
MO knowledge and beliefs (Table I) 
Inconsistencies in type 2 diabetes treatment, and either
unawareness of or inexperience with type 2 diabetes treatment
guidelines were frequently reported.  A gap in knowledge and
training on the initiation of insulin therapy was also identified
by half of the participants.  ‘ For me insulin [was not an
option].  It frightened me because I had no idea how to
[determine] the dosage for the patient.’  Participating MOs
stated that most of the undergraduate training they had
received focused on treatment of acute and complicated
conditions related to diabetes rather than on practical diabetes
management in a primary-care setting.  Many MOs did not
know the benefits of insulin for patients with poorly controlled
type 2 diabetes.
The MOs expressed belief that insulin is not beneficial in
obese patients and may exacerbate obesity, while others
questioned its value in the presence of established
complications.  Many participants were concerned that patients
do not possess the necessary knowledge and understanding of
the disease to use insulin safely. 
Language barrier
Language differences, lack of appropriate educational material
in the patient’s preferred language and suspect interpretation
by interpreters were identified as barriers to communication
and patient education. 
Fear of hypoglycaemia 
Participants were reluctant to initiate treatment, fearing that it
would induce hypoglycaemia in the patient.  This factor
combined with lack of knowledge, confidence and support
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from other MOs and nursing staff inclined them to shift the
responsibility for initiation of insulin therapy to tertiary
hospitals.  ‘There’s not always somebody to ask [for advice]
and there’s no protocol, so the easiest thing is to just send [the
patient] to the hospital ... and let them make the decision for
you.’
Patient non-compliance
Many MOs stated that the majority of their patients were non-
compliant with pharmacotherapy and non-pharmacological
modalities of diabetes treatment, and therefore would not be
compliant with insulin.  
There was also concern that patients did not understand the
long-term impact of poor blood sugar control. ‘They don’t
understand the seriousness of their disease so they don’t
control the disease seriously; the consequence is that they don’t
come to the realisation point that you expect them to.’
In addition, MOs were concerned that patients had more
faith in traditional healers and herbs than in conventional
medicine.
Patient fears
MOs claimed that their patients were resistant and unwilling to
begin insulin treatment because of fear of needles and pain
from injections. One MO mentioned that he had a patient who
did not want to start insulin therapy because she feared it
would damage her relationships with significant others.
Patient socio-economic conditions and age
Poor socio-economic conditions among patients exacerbated
MOs’ fears of hypoglycaemia.  For example, MOs were
concerned that their patients’ ability to care for themselves was
adversely affected by factors such as limited financial
resources, irregular meals, inability to refrigerate their insulin,
and lack of transport and access to telephones to summon help
in an emergency. Blood glucose meters were also thought to be
beyond the means of most patients. Isolation of elderly
patients, poor vision, and lack of understanding, family
support and escorts to hospital were mentioned as difficulties
in initiating insulin therapy in this group.
System barriers (Table II)
Numerous system barriers to the initiation of insulin therapy
were mentioned. Participants explained that an effective health
system was necessary to initiate insulin in CHCs.  Excessive
workload, short consultation times, rapid staff turnover and
lack of continuity of care by the same doctor were barriers
identified by all participants. Additional factors are inadequate
resourcing of the health services leading to inadequate insulin
supply, too few dietitians available for counselling, lack of
good-quality blood glucose meters and constraints on ordering
relevant tests such as glycated haemoglobin.  
Lack of availability of clear clinical guidelines was also cited
as a barrier. 
Table I. Selected quotes from study participants 
MO knowledge, beliefs and fears
‘Initiating insulin in a patient who is not compliant on a diabetic diet and who has morbid obesity is generally not a very good idea.’
‘Insulin is not beneficial because when [patients] come here for treatment they already have complications, so you are not going to
reverse these.’  
‘We are worried about the risk of hypoglycaemia.’ 
‘Not all physicians have the confidence to make the decision themselves and they want a specialist or somebody more senior to make
that decision for them.’
Perceived patient barriers
‘They have wrong ideas of what insulin is and they’ve been told by their friends that they must never start insulin or they’ll get fat and
it is all downhill from there.’
‘They know somebody who takes insulin and then had to have a leg amputation; their perception is that insulin is the cause of leg
amputation, not diabetes.’
‘I discuss it with them, what insulin is, why they need insulin and how it works, and they’re afraid of pain from needles.  This is the
reason they give as an objection.’
‘There is no way that I can go on insulin because my husband will divorce me if I go on insulin’ (patient statement)
Table II. Selected quotes from study participants – system barriers
‘You only have an average of 6 minutes per patient. By the time you’ve examined them and found out that they’re diabetic and what
their glucose level is, you cannot possibly educate somebody in 3 minutes [or less].’
‘I find that when I suggest to a patient that he starts on insulin he might accept the notion originally.  But as soon as I explain to him that
he will have to come back in 3 days or even in 2 weeks, and that he might have to go via another system without an appointment, and
that it will be a very long wait, this becomes a serious barrier to him.’
‘We often turn people away because there are no doctors to follow them up, and there are not enough pharmacists to provide enough
medication for all the people with chronic disorders.  Even if you want to start somebody on insulin, you’re thinking, “Are we going to
be able to supply the insulin?”’
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Lack of continuity of care
Poorly managed appointment systems and long waiting times
as a result of excessive patient loads contributed to lack of
continuity of care; this in turn led to diminished opportunity
for trusting patient-doctor relationships to develop.
Discussion
This study identified numerous doctor, system and patient
barriers to the initiation of insulin therapy.  Many of the themes
identified were similar to the barriers to optimal diabetes care
documented in other countries. These included MOs’ lack of
knowledge and need for further education related to diabetes
care, lack of adherence to evidence-based guidelines, fear of
hypoglycaemia, patient non-compliance, and financial and
time constraints.12-16,18
We reported previously that the South African guidelines on
diabetes and hypertension were not systematically
implemented at local CHCs in Cape Town and that individual
doctors consulted the guidelines infrequently.13 This situation
appears not to have changed since the previous study as many
participants in the present study also reported that they did not
consult type 2 diabetes primary care management guidelines.
Some found the guidelines too complex to apply and did not
find clear instructions on maximum doses of oral glucose-
lowering agents (OGLAs) and use of insulin. This uncertainty
was compounded in that many participants noted
inconsistencies between the maximum OGLA doses in the
South African Medicines Formulary and the doses mentioned in
the guidelines.  Consequently, there was confusion as to
whether insulin should be introduced or the dose of OGLAs
increased.  Clearly, great attention needs to be paid to ensuring
consensus when such documents are developed.
MOs’ perception that insulin is not beneficial for patients
with type 2 diabetes is surprising as it is currently accepted
that type 2 diabetes is a progressive disease for which a
majority of patients will ultimately require insulin;
furthermore, the benefit of improved glycaemic control on
microvascular complications is now evident regardless of mode
of therapy (OGLA or insulin).11 The concern that insulin might
increase obesity is a valid one as good glycaemic control with
sulphonylurea or insulin is associated with weight gain.11
However, the degree of weight gain can be reduced by using a
combination of metformin and insulin rather than insulin alone
or insulin/sulphonylureas, with at least equivalent glycaemic
control.19 These issues highlight the need for and the
importance of ongoing interactive CME sessions.
The MOs’ fear of inducing hypoglycaemia with insulin
therapy is also understandable, particularly in a setting where
regular meals may not be affordable.  Indeed, severe
hypoglycaemia was a significant problem among diabetic
patients presenting with coma at Baragwanath Hospital in
Soweto.20 However hypoglycaemia is preventable through
patient education and cautious prescribing by the practitioner
(starting with low-dose insulin).20,21
A family-orientated primary-care approach using the
maximum support available from family, friends, neighbours,
and the community may address MO concerns about starting
insulin therapy in elderly patients.  Furthermore, there needs to
be recognition that strict glycaemic control may not be
achievable or even desirable in many elderly patients.22 For
example, relief of osmotic diuresis associated with
hyperglycaemia may be an achievable goal leading to
improvement in quality of life.
MO reluctance to initiate insulin in the primary care setting
was also due to perceived lack of patient compliance, as
adherence with current treatment may obviate the need for
insulin.  Patient adherence with therapy is a complex issue, but
the manner in which diabetes care is structured, delivered, and
financed is likely to have a major impact on the ability of
patients to manage their diabetes. The patients cared for by the
MOs in this study were of low socio-economic status and the
care was characterised by long waiting times and short
duration of contact with different MOs, although the service
and medication were free. Cultural differences between
patients and doctors were likely to have hampered self-care
practices.  Regardless of the cause of non-compliance, the MOs’
understanding and effective action to improve adherence needs
to be greatly improved.  Good communication and mutual
decision making between doctor and patient are likely to
improve adherence to a regimen.23 Failure in communication
centres mainly around the perceptions and expectations of
doctors and patients. Patient factors include: misconceptions
about the disease and medication, questioning the necessity of
continuing treatment, feeling well, physical and social
vulnerability and lack of control over their lives, and doubts
about access to and availability of treatment.
An additional reason for patients’ lack of adherence to
diabetes treatment was their belief in traditional healers and
alternative medicine rather than allopathic medicine.  A
trusting doctor-patient relationship is important so that
patients will be encouraged to tell the doctor what alternative
medicine they are using, and may allow for negotiation around
the continued use of allopathic treatment. Misconceptions such
as the belief that insulin may lead to amputations and death
can be addressed through education sessions. These sessions
should involve patients on insulin therapy who relate the
benefits they have experienced.
There was a strong perception that poor socio-economic
conditions impeded patients' compliance with treatment.  Lack
of refrigerators to store insulin was cited as a barrier.
Fortunately, insulin does not need to be refrigerated but merely
kept in a cool place.  Slight loss of potency may occur after a
bottle has been in use for over 30 days if stored at room
temperature.  The participants expressed concern about
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unemployment and poverty.  However, in a UK study,24
glycaemic control was not related to age, social class, lifestyle,
attitude, or knowledge of patients but rather to better facilities,
miniclinics, and doctors with special interest in diabetes. In
addition, education on self-care and blood glucose monitoring
improved glycaemic control in patients attending the
Johannesburg Hospital special clinic despite a high illiteracy
rate.25 The inability of patients to afford blood glucose meters
can be addressed by instructing in the use of a Haemoglucotest
which enables the visual reading of blood glucose levels.
Alternatively, allowance should be made for more frequent
clinic attendance for measurement of blood glucose and
adjustment of insulin dose.  Unfortunately, the latter may be
problematic owing to transport costs and loss of earnings.25
Cost constraints on ordering glycated haemoglobin, with
consequent reliance on a single random blood glucose level test
which may be affected by factors such as size of last meal,
interval from last meal, and stress, can be problematic when
making a decision to initiate insulin therapy.  In addition, the
CHCs' blood glucose measurements are perceived to be
problematic, as the glucose meters are often faulty and poor
technique is often encountered.  This situation needs urgent
attention.
The use of a combination of focus group discussion and in-
depth individual interviews enhanced the validity of this
research.  Participants’ limitations with regard to expressing
their fears in front of other colleagues were noticed, but the
individual interviews helped to provide some exploratory data.
However a major deficiency of the study was the exclusion of
nurses and patients who could have provided a more
comprehensive view on the barriers to initiating insulin
therapy.  
Several actions may be taken to overcome the barriers to
initiating insulin therapy in poorly controlled diabetic patients
on oral medication. Development of uniform and practical
guidelines by experts in the field, with the active participation
of primary health care professionals regarding initiation of
insulin in primary health care settings, would be of value.
Interactive workshops in which these guidelines are introduced
and problems discussed at subsequent meetings should be an
integral part of an effective implementation strategy.  The
introduction of an effective district nursing service would help
in the follow up of elderly and disabled patients who cannot
attend CHCs regularly.  A patient-centred approach may be
useful in improving adherence.  Improved training of nursing
staff in the technique of insulin injections, monitoring,
identifying and treatment of hypoglycaemia, and methods to
provide patient education and involve family members would
be essential. 
The organisation of the health system also requires change. It
would be useful to establish an appointment system that
allows for continuity of care.  An insulin sheet, or other
flowsheet model to guide a systematic approach, with a fast-
tracking mechanism for patients started on insulin so they can
consult briefly with the staff to adjust the dosages, would also
be of benefit. 
The Western Cape CHCs are a model of community health
care in South Africa.  It is likely that these findings and
recommendations are of relevance to all doctors working in
primary health care, at least in this country and possibly
elsewhere.
We would like to acknowledge the assistance of Laurian Vivian
in this study.  The study was partially supported by an
unconditional grant from Eli Lilly Laboratories.
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